Direct-to-Consumer Advertising of Prescription Medications: Implications for Patients With Cancer

Pamela Hallquist Viale

ONF 2002, 29(3), 505-513. DOI: 10.1188/02.ONF.505-513

Purpose/Objectives: To review the phenomenon of direct-to-consumer (DTC) advertising of prescription medications in the media, with an overview of pertinent studies in the literature regarding patients' and healthcare professionals' perspectives on DTC advertising.

Data Sources: Journal articles, media, and clinical experience.

Data Synthesis: DTC advertising of prescription medications is extremely prevalent in U.S. society. Advertising of medications is an expensive business; yearly spending is expected to reach $7.5 billion by 2005. Although opinions vary regarding DTC advertising, healthcare professionals, including oncology nurses, must be prepared to discuss DTC-advertised medications and treatments with their patients.

Conclusions: Communication is the key to helping patients decipher the deluge of DTC advertisements in the media and determine the accuracy of this ever-increasing source of medical information.

Implications for Nursing: Oncology nurses need to be aware of the increases in DTC advertising of prescription medications and the importance of guiding patients through appropriate medication choices by education.

Jump to a section

    References

    Alper, P.R. (1999). Direct to consumer advertising: Education or anathema? [Letter to the editor]. JAMA, 282, 1226--1227. Retrieved July 13, 2001 from http://jama.ama-assn.org/issues/v282m13/ffull/jlt1006--4.html

    American Cancer Society. (2002). Cancer facts and figures. Atlanta: Author.

    Anderson, E.R. (2001). AMA letter to Senator Peter Fitzgerald (R-IL) regarding direct-to-consumer advertising of prescription drugs. Retrieved July 13, 2001 from http://ama-assn.org/ama/pub/article/4051--4805.html

    Baylor-Henry, M., & Drezin, N.A. (1998). Regulation of prescription drug promotion: Direct-to-consumer advertising. Clinical Therapeutics, 20(Suppl. C), C86-C95.

    Bell, R.A., Kravitz, R.L., & Wilkes, M.S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651--657.

    Bell, R.A., Kravitz, R.L., & Wilkes, M.S. (2000). Direct-to-consumer prescription drug advertising, 1989--1998: A content analysis of conditions, targets, inducements, and appeals. Journal of Family Practice, 49, 329--335.

    Bell, R.A., Wilkes, M.S., & Kravitz, R.L. (1999). Advertisement-induced prescription drug requests: Patient's anticipated reactions to a physician who refuses. Journal of Family Practice, 48, 446--452.

    Bell, R.A., Wilkes, M.S., & Kravitz, R.L. (2000). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49, 1092--1098.

    Berger, J.T., Kark, P., Rosner, F., Packer, S., & Bennett, A.J. (2001). Direct-to-consumer drug marketing: Public service or disservice? Mount Sinai Journal of Medicine, 68, 197--202.

    Berkowitz, L., Capizzi, M.D., Breuer, J., & Szuminski, J. (April, 2001). Internet DTC: Minding your Ps and Qs. Pharmaceutical Executive, 21 (4), 124--130.

    Carroll-Johnson, R.M. (2001). Finding information in all the wrong places [Editorial]. Oncology Nursing Forum, 28, 787.

    Clark, P.M., & Gomez, E.G. (2001). Details on demand: Consumers, cancer information, and the Internet. Clinical Journal of Oncology Nursing, 5, 19--24.

    Davis, J.J. (2000). Riskier than we think? The relationship between risk statement completeness and perceptions of direct-to-consumer advertisement of prescription drugs. Journal of Health Communication, 5, 349--369.

    Elliot, V.S. (2001). Questions swirl around drug ads for patients. Retrieved July 12, 2001 from http://www.ama-assn.org/sci-pubs/amnews/pick_01/hll10709.htm

    Findlay, S.D. (2001). Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers, and providers. Pharmacoeconomics, 19, 109--119.

    Goldblatt, D., Beresford, H.R., Bernat, J.L., Mackin, G.A., McQuillen, M.P., Nelson, R.F., et al. (2001). Practice advisory: Participation of neurologists in direct-to-consumer advertising. Neurology, 56, 995--996.

    Gonul, F.F., Carter, F., & Wind, J. (2000). What kind of patients and physicians value direct-to-consumer advertising of prescription drugs? Health Care Management Science, 3, 215--226.

    Goodman, E. (2001, July 21). Side effects may include pain in the pocket-book (Editorial). San Jose Mercury News, p. 7b.

    Hall, S.S. (2001, March 11). Prescription for profit. New York Times Magazine, pp. 40--45, 59, 91--92, 103.

    Henney, J.E. (2000). Challenges in regulating direct-to-consumer advertising. MSJAMA online, 284, 2242. Retrieved July 12, 2001 from http:// www.ama-assn.org/sci-pubs/msjama/articles/vol-284/no-17/ jms00030.htm

    Hoffman, J.R., & Wilkes, M. (1999). Direct-to-consumer advertising of prescription drugs [Editorial]. BMJ, 318, 1301--1302.

    Hollon, M.F. (1999). Direct-to-consumer marketing of prescription drugs: Creating consumer demand. JAMA, 281, 382--384.

    Holmer, A.F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA, 281, 380--382.

    Huang, A.J. (2000). The rise of direct-to-consumer advertising of prescription drugs in the United States. JAMA, 284, 2240.

    Kravitz, R.L. (2000a). Direct-to-consumer advertising of prescription drugs. Western Journal of Medicine, 173, 221--222.

    Kravitz, R.L. (2000b). Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship. JAMA, 284, 2244.

    Lee, R. (2001). Direct-to-consumer advertising: Pharmacoeconomics. Orthopedic Technology Review, 3(1), 30--34.

    Lipsky, M.S., & Taylor, C.A. (1997). The opinions and experiences of family physicians regarding direct-to-consumer advertising. Journal of Family Practice, 45, 495--499.

    Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., et al. (2000). Coverage by the news media of the benefits and risks of medications. New England Journal of Medicine, 342, 1645--1650.

    PDR Getting Well Network. (2001a). Breast cancer. Retrieved July 21, 2001 from http://www.pdr.net/gettingwell/breast_cancer/index.html

    PDR Getting Well Network. (2001b). Depression. Retrieved July 21, 2001 from http://www.pdr.net/gettingwell/depression/index.html

    Peters, J. (2001). The high cost of direct-to-consumer advertising. Minnesota Medicine, 84 (1), 10--15.

    Pines, W.L. (1998). Direct-to-consumer promotion: An industry perspective. Clinical Therapeutics, 20(Suppl. C), C96-C103.

    Pines, W.L. (2000). Direct-to-consumer advertising. Annals of Pharmacotherapy, 34, 1341--1344.

    Read, J.O. (2001). DTC advertising: Obstacle or opportunity. Minnesota Medicine, 84(1), 12--13.

    Reeves, K.N. (1998). Direct-to-consumer broadcast advertising: Empowering the consumer or manipulating a vulnerable population? Food and Drug Law Journal, 53, 661--679.

    Rosner, F., Kark, P., Packer, S., Bennett, A., & Berger, J. (1999). Direct-to-consumer advertising: Education or anathema? [Letter to the editor]. JAMA, 282, 1227. Retrieved July 13, 2001 from http://jama.ama-assn.org/issues/v282m13/ffull/jlt1006--4.html

    Sansgiry, S., Sharp, W.T., & Sansgiry, S.S. (1999). Accuracy of information on printed over-the-counter drug advertisements. Health Mark Q, 17 (2), 7--18.

    Sellers, J.A. (2000). The two faces of direct-to-consumer advertising [Editorial]. American Journal Health-System Pharmacy, 57, 1401.

    Spurgeon, D. (1999). Doctors feel pressurised by direct to consumer advertising. BMJ, 319, 1321.

    Steinman, M.A. (2000). Gifts to physicians in the consumer-marketing era. JAMA, 284, 2243.

    Tanne, J.H. (1999). Direct-to-consumer drug advertising is billion-dollar business in U.S. British Medical Journal, 319, 805.

    U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (1999). Guidance for industry: Consumer-directed broadcast advertisements. Retrieved August 21, 2001 from http://www.fda.gov/ cder/guidance/1804q&a.htm

    U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2001a). Attitudes and behaviors associated with direct-to-consumer (DTC) promotion of prescription drugs: Main survey results. Retrieved July 12, 2001 from http://www.fda.gov/cder/ddmac/dtcindex.htm

    U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2001b). Guidance for industry: Using FDA-approved labeling in consumer-directed print advertisements [Draft]. Retrieved October 1, 2001 from http://www.fda.gov/cder/guidance/4114dft.pdf.